SEC Filing

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717 

SEC Filing Details

Document Details

Form
Filing Date
Mar 14, 2014
Document Date
Mar 9, 2014
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Jazz Pharmaceuticals plc
Issuer
JAZZ PHARMACEUTICALS PLC
Filer
Young Matthew P.